Active Ingredient History
Hydrocortisone hemisuccinate (USAN), also known as hydrocortisone hydrogen succinate (BANM) or simply hydrocortisone succinate and sold under the brand name Solu-Cortel among many others, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester which is used for antiinflammatory and antiallergic indications. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adrenal Hyperplasia, Congenital (approved 1952)
Arthritis, Rheumatoid (approved 1952)
Leukemia (approved 1952)
Addison Disease (Phase 4)
Adrenal Cortex Hormones (Phase 2)
Adrenal Gland Diseases (Phase 1/Phase 2)
Adrenal Gland Neoplasms (Phase 1/Phase 2)
Adrenal Hyperplasia, Congenital (Phase 4)
Adrenal Insufficiency (Phase 4)
Adrenocortical Hyperfunction (Phase 1/Phase 2)
Adult (Phase 2/Phase 3)
Alcohol Drinking (Early Phase 1)
Allografts (Phase 3)
Atrial Fibrillation (Phase 2/Phase 3)
Blood Pressure (Early Phase 1)
Burkitt Lymphoma (Phase 2)
Cigarette Smoking (Phase 1)
Cocaine-Related Disorders (Early Phase 1)
Colitis (Phase 1/Phase 2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Phase 1/Phase 2)
COVID-19 (Phase 3)
Critical Illness (Phase 2/Phase 3)
Cyclosteroids (Phase 3)
Deficiency Diseases (Phase 4)
Depression (Phase 4)
Disorders of Sex Development (Phase 1/Phase 2)
Down Syndrome (Phase 2)
Drinking Behavior (Early Phase 1)
Drugs, Investigational (Phase 4)
Dry Eye Syndromes (Phase 4)
Eczema (Phase 4)
Fasting (Phase 4)
Fibrosis (Phase 4)
Genetic Diseases, Inborn (Phase 1/Phase 2)
Granulomatous Mastitis (Phase 4)
Healthy Volunteers (Phase 4)
Heart Rate (Early Phase 1)
Hemorrhoids (Phase 3)
HIV (Early Phase 1)
Hydrocortisone (Phase 4)
Hyperplasia (Phase 1/Phase 2)
Hypoxia (Phase 3)
Influenza, Human (Phase 1/Phase 2)
Intertrigo (Phase 4)
Kidney Diseases (Phase 3)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, T-Cell (Phase 1)
Lipomatosis, Multiple Symmetrical (Phase 3)
Low Back Pain (Phase 3)
Lumbar Vertebrae (Phase 4)
Lymphoma (Phase 2)
Lymphoma, T-Cell (Phase 1)
Meibomian Gland Dysfunction (Phase 4)
Memory, Episodic (Early Phase 1)
Memory, Long-Term (Early Phase 1)
Metabolic Diseases (Phase 2/Phase 3)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Opioid-Related Disorders (Phase 2)
Osteoarthritis, Knee (Phase 4)
Pain (Phase 4)
Pancreatitis (Phase 2)
Polymyalgia Rheumatica (Phase 2)
Post-Cardiac Arrest Syndrome (Phase 3)
Post-Dural Puncture Headache (Phase 4)
Proctitis (Phase 3)
Psoriasis (Phase 1)
Psychological Distress (Phase 2)
Sepsis (Phase 4)
Severe Acute Respiratory Syndrome (Phase 1/Phase 2)
Shock, Cardiogenic (Phase 3)
Shock, Septic (Phase 4)
Sleep Disorders, Intrinsic (Early Phase 1)
Spinal Injuries (Phase 3)
Steroid Metabolism, Inborn Errors (Phase 1/Phase 2)
Stress Disorders, Post-Traumatic (Phase 2)
Stress Disorders, Traumatic, Acute (Phase 2)
Tacrolimus (Phase 1/Phase 2)
Thoracic Surgery (Phase 3)
Traumatology (Phase 2)
Urogenital Abnormalities (Phase 1/Phase 2)
Vasoconstriction (Phase 1)
Vasoplegia (Phase 3)
Vitiligo (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
